These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1080583)

  • 1. [Activity of toloxatone, antidepressive agents and various other reserpine antagonists on three behavior tests, in the mouse treated with nialamide].
    Gouret C; Raynaud G
    Therapie; 1975; 30(2):225-30. PubMed ID: 1080583
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of pharmacological activity and toxicity of the antidepressants nialamide, phenelzine and iproniazide].
    Lapin IP; Samsonova ML
    Farmakol Toksikol; 1969; 32(5):526-30. PubMed ID: 5364661
    [No Abstract]   [Full Text] [Related]  

  • 5. Emetic effect of biogenic amines.
    Cahen RL
    Res Clin Stud Headache; 1970; 3():227-44. PubMed ID: 4144415
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL; Tagliamonte A
    Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of some drugs on the immune response. 3. Effect of serotonin, 5-hydroxytryptophan, reserpine, monoamine oxidase inhibitors, and DOPA on the involvement of lymph node cells in the immune response.
    Devoino LV; Yeliseyeva LS
    Eur J Pharmacol; 1971; 14(1):71-6. PubMed ID: 5313885
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 11. [2-(2-Thienyl)morpholines with CNS activity].
    Carissimi M; Picciòla G; Ravenna F; Carenini G; Gentili P
    Farmaco Sci; 1980 Oct; 35(10):812-25. PubMed ID: 6969667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies with N-3,4,5-trimethoxybenzoyl-heptamethylene imine (N-1157), a new antidepressant agent.
    Pálosi E; Mészáros C; Szporny L
    Arzneimittelforschung; 1969 Nov; 19(11):1882-7. PubMed ID: 5395660
    [No Abstract]   [Full Text] [Related]  

  • 14. Microspectrofluorimetric studies on central 5-hydroxytryptamine neurons.
    Jonsson G; Einarsson P; Fuxe K; Hallman H
    Adv Biochem Psychopharmacol; 1974; 10():55-65. PubMed ID: 4276959
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional aspects of 5-hydroxytryptamine turnover in the central nervous system.
    Modigh K
    Acta Physiol Scand Suppl; 1974; 403():1-56. PubMed ID: 4275711
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-amino-2-oxazoline derivative as an antidepressant in mice.
    Bourin M; Creuzet MH; Jarry C; Colombel MC
    Arzneimittelforschung; 1988 May; 38(5):666-8. PubMed ID: 3261982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replenishment by 5-hydroxytryptophan of the amine stores in the central 5-hydroxytryptamine neurons after depletion induced by reserpine or by an inhibitor of monoamine synthesis.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1967 Jul; 19(7):433-8. PubMed ID: 4382634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biosynthesis and metabolism of indolamines in the pineal organ of Lacerta (reptiles, larcertilians). II. Monoamine oxidase activity and incorporation of 3H-5-HTP and 3H-5-HT under normal and experimental conditions].
    Collin JP; Meiniel A
    Z Zellforsch Mikrosk Anat; 1973 Dec; 145(3):331-61. PubMed ID: 4543951
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine.
    Florvall L; Ask AL; Ogren SO; Ross SB
    J Med Chem; 1978 Jan; 21(1):56-63. PubMed ID: 22755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.